Aisling Capital Management LP Harmony Biosciences Holdings, Inc. Transaction History

Aisling Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$33.54 - $52.15 $11.5 Million - $17.9 Million	-342,815 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$33.14 - $51.13 $417,564 - $644,238	-12,600 Reduced 3.55%	342,815 $16.7 Million
Q4 2021 Feb 18, 2022	SELL	$34.09 - $43.91 $8.09 Million - $10.4 Million	-237,400 Reduced 40.05%	355,415 $15.2 Million
Q3 2021 Nov 12, 2021	SELL	$25.68 - $38.61 $6.42 Million - $9.65 Million	-250,000 Reduced 29.66%	592,815 $22.7 Million
Q3 2020 Nov 12, 2020	BUY	$30.96 - $44.39 $26.1 Million - $37.4 Million	842,815 New	842,815 $28.6 Million

233

45.2M

48.2K

56.5K

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.07B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

Get notified when there are updates to the investment portfolio of Aisling Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Aisling Capital Management LP with notifications on news.